Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

63 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
1-Year Outcomes of Patients Undergoing Primary Angioplasty for Myocardial Infarction Treated With Prasugrel Versus Ticagrelor.
Motovska Z, Hlinomaz O, Kala P, Hromadka M, Knot J, Varvarovsky I, Dusek J, Jarkovsky J, Miklik R, Rokyta R, Tousek F, Kramarikova P, Svoboda M, Majtan B, Simek S, Branny M, Mrozek J, Cervinka P, Ostransky J, Widimsky P; PRAGUE-18 Study Group. Motovska Z, et al. Among authors: mrozek j. J Am Coll Cardiol. 2018 Jan 30;71(4):371-381. doi: 10.1016/j.jacc.2017.11.008. Epub 2017 Nov 14. J Am Coll Cardiol. 2018. PMID: 29154813 Free article. Clinical Trial.
Prasugrel Versus Ticagrelor in Patients With Acute Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention: Multicenter Randomized PRAGUE-18 Study.
Motovska Z, Hlinomaz O, Miklik R, Hromadka M, Varvarovsky I, Dusek J, Knot J, Jarkovsky J, Kala P, Rokyta R, Tousek F, Kramarikova P, Majtan B, Simek S, Branny M, Mrozek J, Cervinka P, Ostransky J, Widimsky P; PRAGUE-18 Study Group. Motovska Z, et al. Among authors: mrozek j. Circulation. 2016 Nov 22;134(21):1603-1612. doi: 10.1161/CIRCULATIONAHA.116.024823. Epub 2016 Aug 30. Circulation. 2016. PMID: 27576777 Clinical Trial.
Cangrelor With and Without Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Coronary Intervention.
Vaduganathan M, Harrington RA, Stone GW, Deliargyris EN, Steg PG, Gibson CM, Hamm CW, Price MJ, Menozzi A, Prats J, Elkin S, Mahaffey KW, White HD, Bhatt DL; CHAMPION Investigators. Vaduganathan M, et al. J Am Coll Cardiol. 2017 Jan 17;69(2):176-185. doi: 10.1016/j.jacc.2016.10.055. J Am Coll Cardiol. 2017. PMID: 28081827 Free article. Clinical Trial.
Safety of early discharge in low risk patients after acute ST-segment elevation myocardial infarction, treated with primary percutaneous coronary intervention. Open label, randomized trial.
Novobilsky K, Stipal R, Cerny P, Horak I, Kaucak V, Mrozek J, Vaclavik J, Kryza R. Novobilsky K, et al. Among authors: mrozek j. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2019 Feb;163(1):61-66. doi: 10.5507/bp.2018.041. Epub 2018 Aug 28. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2019. PMID: 30181666 Free article. Clinical Trial.
Prediction Score for persisting perfusion defects after pulmonary embolism.
Mrozek J, Necasova T, Svoboda M, Simkova I, Jansa P. Mrozek J, et al. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2020 Dec;164(4):394-400. doi: 10.5507/bp.2019.033. Epub 2019 Sep 13. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2020. PMID: 31551608 Free article.
The prognostic significance of periprocedural infarction in the era of potent antithrombotic therapy. The PRAGUE-18 substudy.
Dusek J, Motovska Z, Hlinomaz O, Miklik R, Hromadka M, Varvarovsky I, Jarkovsky J, Tousek F, Majtan B, Simek S, Branny M, Mrozek J, Widimsky P; Prague-18 Study Group. Dusek J, et al. Among authors: mrozek j. Int J Cardiol. 2020 Nov 15;319:1-6. doi: 10.1016/j.ijcard.2020.06.067. Epub 2020 Jul 4. Int J Cardiol. 2020. PMID: 32634499
The Effect of Diabetes on Prognosis Following Myocardial Infarction Treated with Primary Angioplasty and Potent Antiplatelet Therapy.
Simek S, Motovska Z, Hlinomaz O, Kala P, Hromadka M, Knot J, Varvarovsky I, Dusek J, Rokyta R, Tousek F, Svoboda M, Vodzinska A, Mrozek J, Jarkovsky J, On Behalf Of The Prague-Study Group. Simek S, et al. Among authors: mrozek j. J Clin Med. 2020 Aug 6;9(8):2555. doi: 10.3390/jcm9082555. J Clin Med. 2020. PMID: 32781780 Free PMC article.
Ticagrelor versus clopidogrel in elective percutaneous coronary intervention (ALPHEUS): a randomised, open-label, phase 3b trial.
Silvain J, Lattuca B, Beygui F, Rangé G, Motovska Z, Dillinger JG, Boueri Z, Brunel P, Lhermusier T, Pouillot C, Larrieu-Ardilouze E, Boccara F, Labeque JN, Guedeney P, El Kasty M, Laredo M, Dumaine R, Ducrocq G, Collet JP, Cayla G, Blanchart K, Kala P, Vicaut E, Montalescot G; ALPHEUS investigators. Silvain J, et al. Lancet. 2020 Nov 28;396(10264):1737-1744. doi: 10.1016/S0140-6736(20)32236-4. Epub 2020 Nov 14. Lancet. 2020. PMID: 33202219 Free article. Clinical Trial.
Ischemic Events Occur Early in Patients Undergoing Percutaneous Coronary Intervention and Are Reduced With Cangrelor: Findings From CHAMPION PHOENIX.
Cavender MA, Harrington RA, Stone GW, Steg PG, Gibson CM, Hamm CW, Price MJ, Lopes RD, Leonardi S, Deliargyris EN, Prats J, Mahaffey KW, White HD, Bhatt DL; CHAMPION PHOENIX Investigators*. Cavender MA, et al. Circ Cardiovasc Interv. 2022 Jan;15(1):e010390. doi: 10.1161/CIRCINTERVENTIONS.120.010390. Epub 2021 Dec 17. Circ Cardiovasc Interv. 2022. PMID: 34915723 Free PMC article. Clinical Trial.
The relationship between symptom onset-to-needle time and ischemic outcomes in patients with acute myocardial infarction treated with primary PCI: Observations from Prague-18 Study.
Hromadka M, Motovska Z, Hlinomaz O, Kala P, Varvarovsky I, Dusek J, Svoboda M, Jarkovsky J, Tousek F, Jansky P, Simek S, Branny M, Mrozek J, Miklik R, Rokyta R, Widimsky P. Hromadka M, et al. Among authors: mrozek j. J Cardiol. 2022 May;79(5):626-633. doi: 10.1016/j.jjcc.2021.11.015. Epub 2021 Dec 16. J Cardiol. 2022. PMID: 34924237 Free article. Clinical Trial.
63 results